日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

卡博替尼治疗晚期神经内分泌肿瘤的3期临床试验

Chan, Jennifer A; Geyer, Susan; Zemla, Tyler; Knopp, Michael V; Behr, Spencer; Pulsipher, Sydney; Ou, Fang-Shu; Dueck, Amylou C; Acoba, Jared; Shergill, Ardaman; Wolin, Edward M; Halfdanarson, Thorvardur R; Konda, Bhavana; Trikalinos, Nikolaos A; Tawfik, Bernard; Raj, Nitya; Shaheen, Shagufta; Vijayvergia, Namrata; Dasari, Arvind; Strosberg, Jonathan R; Kohn, Elise C; Kulke, Matthew H; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial

比较度伐利尤单抗、奥拉帕尼和西地尼布单药治疗、联合治疗或化疗治疗既往接受过贝伐珠单抗治疗的铂耐药卵巢癌患者的疗效:II期NRG-GY023试验

Lee, Jung-Min; Miller, Austin; Rose, Peter G; AlHilli, Mariam; Washington, Christina; John, Veena S; Shah, Chirag A; Matsuo, Koji; Siedel, Jean; Miller, David S; Hopp, Elizabeth E; O'Shea, Andrea; Chan, John K; Bradford, Leslie S; Morse, Christopher B; Nagel, Christa I; Rodabaugh, Kerry J; Kohn, Elise C; Moore, Kathleen N; Liu, Joyce F

A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era

2024年美国国家癌症研究所/妇科癌症指导委员会子宫内膜癌临床试验规划会议工作组报告:在免疫疗法时代完善子宫内膜癌的治疗方法

Cosgrove, Casey M; Zamarin, Dmitriy; Conejo-Garcia, Jose R; Hacker, Kari E; Vargas, Roberto; Konstantinopoulos, Panagiotis A; Mahdi, Haider S; Gaillard, Stephanie; Markovina, Stephanie; Kohn, Elise C; Adams, Sarah F

The Diverse Aspects of Uterine Serous Cancer: an NCI workshop on the status of and opportunities for advancement of research

子宫浆液性癌的多元方面:美国国家癌症研究所关于研究现状及发展机遇的研讨会

Janakiram, Naveena B; Clarke, Megan A; Kai, Mihoko; Wallace, Tiffany A; Russo, Sandra; Hecht, Toby T; Kohn, Elise C; Heckman-Stoddard, Brandy

Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants

健康参与者血管组生物标志物生物学变异性随时间变化的特征分析

Liu, Yingmiao; Li, Jiatong; Lyu, Jing; Howard, Lauren E; Sibley, Alexander B; Starr, Mark D; Brady, John C; Arrowood, Christy; Kohn, Elise C; Ivy, S Percy; Hurwitz, Herbert I; Abbruzzese, James L; Owzar, Kouros; Nixon, Andrew B

Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005

在铂类耐药或原发性铂类难治性卵巢癌中,西地尼布联合奥拉帕尼与单用西地尼布或奥拉帕尼,或化疗的疗效比较:NRG-GY005

Lee, Jung-Min; Brady, Mark F; Miller, Austin; Moore, Richard G; MacKay, Helen; McNally, Leah; Lea, Jayanthi; Street, Daron; Lheureux, Stephanie; McDonald, Megan E; Duska, Linda R; Cantuaria, Guilherme; Kavecansky, Juraj; Leath, Charles A 3rd; Powell, Matthew; Cadungog, Mark G; Rose, Peter G; Kim, Yong-Man; Huang, Helen Q; Provencher, Michèle; Wenzel, Lari B; Bookman, Michael A; Kohn, Elise C; Secord, Angeles Alvarez

Vaccination of Adults With Cancer: ASCO Guideline

成人癌症患者疫苗接种:ASCO 指南

Kamboj, Mini; Bohlke, Kari; Baptiste, Deana M; Dunleavy, Kieron; Fueger, Abbey; Jones, Lee; Kelkar, Amar H; Law, Lisa Y; LeFebvre, Kristine B; Ljungman, Per; Miller, Eric D; Meyer, Larissa A; Moore, Heather N; Soares, Heloisa P; Taplitz, Randy A; Woldetsadik, Edom S; Kohn, Elise C

Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses

吉西他滨联合或不联合ATR抑制剂Berzosertib治疗铂类耐药卵巢癌的随机II期研究:最终总生存期和生物标志物分析

Konstantinopoulos, Panagiotis A; Cheng, Su-Chun; Lee, Elizabeth K; da Costa, Alexandre André B A; Gulhan, Doga; Wahner Hendrickson, Andrea E; Kochupurakkal, Bose; Kolin, David L; Kohn, Elise C; Liu, Joyce F; Penson, Richard T; Stover, Elizabeth H; Curtis, Jennifer; Sawyer, Hannah; Polak, Madeline; Chowdhury, Dipanjan; D'Andrea, Alan D; Färkkilä, Anniina; Shapiro, Geoffrey I; Matulonis, Ursula A

How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting

如何优化和评估妇科癌症临床试验中的多样性:巴塞罗那妇科肿瘤免疫组化小组会议声明

Sehouli, Jalid; Boer, Jolijn; Brand, Alison H; Oza, Amit M; O'Donnell, Jennifer; Bennett, Katherine; Glaspool, Ros; Lee, Chee Khoon; Ethier, Josee-Lyne; Harter, Philipp; Seebacher-Shariat, Veronika; Chang, Ting-Chang; Cohen, Paul A; van Gorp, Toon; Chavez-Blanco, Adriana; Welch, Stephen; Hranovska, Hanna; O'Toole, Sharon; Lok, Christianne A R; Madariaga, Ainhoa; Rauh-Hain, Jose Alejandro; Perez Fidalgo, Alejandro; Tan, David; Michels, Judith; Pothuri, Bhavana; Fujiwara, Noriko; Rosengarten, Ora; Nishio, Hiroshi; Kim, Se Ik; Mukopadhyay, Asima; Piovano, Elisa; Cecere, Sabrina Chiara; Kohn, Elise C; Mukherjee, Uma; Nasser, Sara; Lindemann, Kristina; Croke, Jennifer; Chen, Xiaojun; Geissler, Franziska; Bookman, Michael A

Vaccination of Adults With Cancer: ASCO Guideline Clinical Insights

成人癌症患者疫苗接种:ASCO 指南临床见解

Kamboj, Mini; Bohlke, Kari; Kohn, Elise C